Canopy Growth Future Growth
Future criteria checks 1/6
Canopy Growth is forecast to grow earnings and revenue by 81% and 7.2% per annum respectively while EPS is expected to decline by 6.7% per annum.
Key information
81.0%
Earnings growth rate
-6.7%
EPS growth rate
Pharmaceuticals earnings growth | 65.0% |
Revenue growth rate | 7.2% |
Future return on equity | n/a |
Analyst coverage | Good |
Last updated | 17 Dec 2024 |
Recent future growth updates
Recent updates
Canopy Growth Corporation (TSE:WEED) Stock Rockets 28% As Investors Are Less Pessimistic Than Expected
Nov 05More Unpleasant Surprises Could Be In Store For Canopy Growth Corporation's (TSE:WEED) Shares After Tumbling 26%
Aug 28We Think Canopy Growth (TSE:WEED) Has A Fair Chunk Of Debt
Aug 17Some Confidence Is Lacking In Canopy Growth Corporation (TSE:WEED) As Shares Slide 26%
Jun 15Canopy Growth Corporation's (TSE:WEED) 77% Share Price Surge Not Quite Adding Up
Apr 20More Unpleasant Surprises Could Be In Store For Canopy Growth Corporation's (TSE:WEED) Shares After Tumbling 28%
Feb 23Analysts Have Been Trimming Their Canopy Growth Corporation (TSE:WEED) Price Target After Its Latest Report
Feb 13Why We're Not Concerned Yet About Canopy Growth Corporation's (TSE:WEED) 42% Share Price Plunge
Dec 22Is Canopy Growth (TSE:WEED) A Risky Investment?
Sep 17With A 31% Price Drop For Canopy Growth Corporation (TSE:WEED) You'll Still Get What You Pay For
Apr 17Is Canopy Growth (TSE:WEED) Using Too Much Debt?
Mar 21Earnings Update: Canopy Growth Corporation (TSE:WEED) Just Reported And Analysts Are Trimming Their Forecasts
Feb 12Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
3/31/2027 | 321 | -118 | -70 | -63 | 3 |
3/31/2026 | 299 | -130 | -99 | -89 | 6 |
3/31/2025 | 274 | -293 | -131 | -132 | 9 |
9/30/2024 | 280 | -586 | -167 | -160 | N/A |
6/30/2024 | 287 | -602 | -191 | -185 | N/A |
3/31/2024 | 297 | -484 | -286 | -282 | N/A |
12/31/2023 | 293 | -999 | -407 | -400 | N/A |
9/30/2023 | 299 | -991 | -520 | -511 | N/A |
6/30/2023 | 317 | -1,025 | -576 | -566 | N/A |
3/31/2023 | 333 | -3,079 | -568 | -558 | N/A |
12/31/2022 | 367 | -3,051 | -559 | -544 | N/A |
9/30/2022 | 423 | -2,938 | -583 | -568 | N/A |
6/30/2022 | 466 | -2,766 | -550 | -521 | N/A |
3/31/2022 | 476 | -255 | -594 | -546 | N/A |
12/31/2021 | 557 | -428 | -587 | -517 | N/A |
9/30/2021 | 569 | -1,223 | -552 | -437 | N/A |
6/30/2021 | 572 | -1,244 | -644 | -513 | N/A |
3/31/2021 | 547 | -1,745 | -622 | -466 | N/A |
12/31/2020 | 506 | -2,348 | -803 | -579 | N/A |
9/30/2020 | 477 | -1,535 | -1,033 | -681 | N/A |
6/30/2020 | 419 | -1,244 | -1,282 | -733 | N/A |
3/31/2020 | 399 | -1,321 | -1,495 | -773 | N/A |
12/31/2019 | 385 | -415 | -1,610 | -802 | N/A |
9/30/2019 | 344 | -256 | -1,578 | -709 | N/A |
6/30/2019 | 291 | -832 | -1,408 | -626 | N/A |
3/31/2019 | 226 | -736 | -1,254 | -535 | N/A |
12/31/2018 | 155 | -398 | -958 | -332 | N/A |
9/30/2018 | 94 | -464 | -709 | -257 | N/A |
6/30/2018 | 88 | -148 | N/A | -137 | N/A |
3/31/2018 | 78 | -67 | N/A | -82 | N/A |
12/31/2017 | 70 | -21 | N/A | -60 | N/A |
9/30/2017 | 58 | -19 | N/A | -41 | N/A |
6/30/2017 | 49 | -13 | N/A | -36 | N/A |
3/31/2017 | 40 | -8 | N/A | -27 | N/A |
12/31/2016 | 30 | -1 | N/A | -14 | N/A |
9/30/2016 | 24 | -7 | N/A | -15 | N/A |
6/30/2016 | 18 | -8 | N/A | -14 | N/A |
3/31/2016 | 13 | -3 | N/A | -14 | N/A |
12/31/2015 | 8 | 0 | N/A | -14 | N/A |
9/30/2015 | 6 | 1 | N/A | -12 | N/A |
6/30/2015 | 3 | -5 | N/A | -10 | N/A |
3/31/2015 | 2 | -7 | N/A | -9 | N/A |
12/31/2014 | 1 | -9 | N/A | -10 | N/A |
9/30/2014 | 1 | -7 | N/A | -8 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: WEED is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: WEED is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: WEED is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: WEED's revenue (7.2% per year) is forecast to grow faster than the Canadian market (7.1% per year).
High Growth Revenue: WEED's revenue (7.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if WEED's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/22 04:36 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Canopy Growth Corporation is covered by 30 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Aaron Grey | Alliance Global Partners |
Frederico Yokota Choucair Gomes | ATB Capital Markets |
Gaurav Jain | Barclays |